CLINICAL TRIALS PROFILE FOR ACETAZOLAMIDE
✉ Email this page to a colleague
All Clinical Trials for acetazolamide
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00000115 ↗ | Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema | Completed | National Eye Institute (NEI) | Phase 2 | 1990-12-01 | To test the efficacy of acetazolamide for the treatment of uveitis-associated cystoid macular edema. |
NCT00004802 ↗ | Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders | Completed | Ohio State University | Phase 3 | 1992-06-01 | OBJECTIVES: I. Assess the efficacy of dichlorphenamide in the treatment of episodic weakness attacks in patients with hyperkalemic periodic paralysis, paramyotonia congenita with periodic paralysis, and hypokalemic periodic paralysis. |
NCT00004802 ↗ | Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders | Completed | National Center for Research Resources (NCRR) | Phase 3 | 1992-06-01 | OBJECTIVES: I. Assess the efficacy of dichlorphenamide in the treatment of episodic weakness attacks in patients with hyperkalemic periodic paralysis, paramyotonia congenita with periodic paralysis, and hypokalemic periodic paralysis. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for acetazolamide
Condition Name
Clinical Trial Locations for acetazolamide
Trials by Country
Clinical Trial Progress for acetazolamide
Clinical Trial Phase
Clinical Trial Sponsors for acetazolamide
Sponsor Name